Hao Enkui, Mukhopadhyay Partha, Cao Zongxian, Erdélyi Katalin, Holovac Eileen, Liaudet Lucas, Lee Wen-Shin, Haskó György, Mechoulam Raphael, Pacher Pál
Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America.
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Mol Med. 2015 Jan 6;21(1):38-45. doi: 10.2119/molmed.2014.00261.
Doxorubicin (DOX) is a widely used, potent chemotherapeutic agent; however, its clinical application is limited because of its dose-dependent cardiotoxicity. DOX's cardiotoxicity involves increased oxidative/nitrative stress, impaired mitochondrial function in cardiomyocytes/endothelial cells and cell death. Cannabidiol (CBD) is a nonpsychotropic constituent of marijuana, which is well tolerated in humans, with antioxidant, antiinflammatory and recently discovered antitumor properties. We aimed to explore the effects of CBD in a well-established mouse model of DOX-induced cardiomyopathy. DOX-induced cardiomyopathy was characterized by increased myocardial injury (elevated serum creatine kinase and lactate dehydrogenase levels), myocardial oxidative and nitrative stress (decreased total glutathione content and glutathione peroxidase 1 activity, increased lipid peroxidation, 3-nitrotyrosine formation and expression of inducible nitric oxide synthase mRNA), myocardial cell death (apoptotic and poly[ADP]-ribose polymerase 1 [PARP]-dependent) and cardiac dysfunction (decline in ejection fraction and left ventricular fractional shortening). DOX also impaired myocardial mitochondrial biogenesis (decreased mitochondrial copy number, mRNA expression of peroxisome proliferator-activated receptor γ coactivator 1-alpha, peroxisome proliferator-activated receptor alpha, estrogen-related receptor alpha), reduced mitochondrial function (attenuated complex I and II activities) and decreased myocardial expression of uncoupling protein 2 and 3 and medium-chain acyl-CoA dehydrogenase mRNA. Treatment with CBD markedly improved DOX-induced cardiac dysfunction, oxidative/nitrative stress and cell death. CBD also enhanced the DOX-induced impaired cardiac mitochondrial function and biogenesis. These data suggest that CBD may represent a novel cardioprotective strategy against DOX-induced cardiotoxicity, and the above-described effects on mitochondrial function and biogenesis may contribute to its beneficial properties described in numerous other models of tissue injury.
阿霉素(DOX)是一种广泛使用的强效化疗药物;然而,由于其剂量依赖性心脏毒性,其临床应用受到限制。DOX的心脏毒性涉及氧化/硝化应激增加、心肌细胞/内皮细胞线粒体功能受损以及细胞死亡。大麻二酚(CBD)是大麻中的一种非精神活性成分,在人体中耐受性良好,具有抗氧化、抗炎以及最近发现的抗肿瘤特性。我们旨在探讨CBD在已建立的DOX诱导的心肌病小鼠模型中的作用。DOX诱导的心肌病表现为心肌损伤增加(血清肌酸激酶和乳酸脱氢酶水平升高)、心肌氧化和硝化应激(总谷胱甘肽含量和谷胱甘肽过氧化物酶1活性降低;脂质过氧化、3-硝基酪氨酸形成增加以及诱导型一氧化氮合酶mRNA表达增加)、心肌细胞死亡(凋亡和聚[ADP]-核糖聚合酶1[PARP]依赖性)以及心脏功能障碍(射血分数和左心室缩短分数下降)。DOX还损害心肌线粒体生物合成(线粒体拷贝数减少、过氧化物酶体增殖物激活受体γ共激活因子1-α、过氧化物酶体增殖物激活受体α、雌激素相关受体α的mRNA表达降低)、降低线粒体功能(复合体I和II活性减弱)以及降低心肌解偶联蛋白2和3以及中链酰基辅酶A脱氢酶mRNA的表达。用CBD治疗可显著改善DOX诱导的心脏功能障碍、氧化/硝化应激和细胞死亡。CBD还增强了DOX诱导的受损心脏线粒体功能和生物合成。这些数据表明,CBD可能代表一种针对DOX诱导的心脏毒性的新型心脏保护策略,并且上述对线粒体功能和生物合成的影响可能有助于其在许多其他组织损伤模型中所描述的有益特性。